The clustering of breast cancer tumours has identified the three following main groups: oestrogen-receptor positive tumours (luminal), oestrogen-receptor negative and Her2-positive tumours, and oestrogen-receptor negative and Her2-negative tumours. Here, ERBB2 is linked to breast carcinoma.